Sitemap - 2022 - MS-Selfie
Are you lonesome this Christmas?
Oscillopsia and double vision in MS
St Elsewhere Hospital - delayed MS diagnosis
Cerebellum: how accurate is your MS history?
Inappropriate laughing and crying
ECTRIMS 2022 - initial thoughts
EBV & MS - repeating oneself is often a good thing
Is there a place for using mitoxantrone to treat MS?
Multiple sclerosis with a near-normal MRI
Brain Health: how important is it?
How strong is your pelvic floor?
How to interpret a urine dipstick result
Is primary progressive MS a different disease?
CAR T-cells as a treatment for MS
More evidence that EBV causes MS
Tinnitus: don't always blame MS
Gaslighting: an institutional problem
The rationale for derisking DMTs
Reflections: setting priorities for MS
MMR vaccine: to vaccinate or not?
Falls: is there anything that can be done to help?
Case study: oscillopsia or jumpy vision
We have a winner: crossword #2 results
Early reflections from the EAN 2022
Answers to the MS-Selfie Crossword
Why is natalizumab not licensed to treat progressive MS?
Grit: do you have what it takes?
Queen Elizabeth II diagnosed with multiple sclerosis
BTK inhibitors - will they deliver?
Time matters: should British people with MS accept sup-optimal care?
Case study: how much brain have you lost?
Can you have a relapse affecting the same site?
What is on the horizon for MS?
What is my neurofilament level doing?
Case study: unrealistic expectations
Waist-to-height ratio, metabolic health and MS
Case study: Copaxone, menstruation and the menopause
Case study: is it too late to treat my MS?
Why did subcutaneous natalizumab (Tysabri) get rejected by the FDA?
War: a forgotten social determinant of health
Exercise, exercise, exercise ... how important is it?
Is there still a role for glatiramer acetate in the management of MS?
Case study: stress as trigger of relapses
Making the case for antiviral therapies in MS
Prof G's backstory: why he became an MSologist
Case study: does treating MS early improve survival?
Serum neurofilament levels - another one bites the dust?
COVID-19 update: the BA.2 variant and miscellanea
Is there still a role for interferon-beta in the management of MS?
Research: big data and smouldering MS
Are you and your family taking vitamin D supplements?
Case study: why cladribine is the better option in this case than ocrelizumab
Case study: why is having another autoimmune disease a contraindication to alemtuzumab?
More evidence that EBV is the cause of MS
Case study: is delayed or adaptive ocrelizumab dosing safer?